Navigating the Drug Development Process – We Understand Your Business

Pharmaceutical manufacturers lose revenue when regulatory deadlines are not met, or when data quality is poor and a test must be repeated. They want a CRO that can manage all testing needs in the drug development process, from start to finish, and with the flexibility to provide solutions that meet their particular needs.

Synomics works with you to identify your specific needs. We have developed a team of experts capable of thinking through the entire pharmaceutical drug development process, from the drug discovery phase through commercial sales. With a strong emphasis on clear communication and greater attention to details, Synomics Pharma creates the right solutions for your business.

Synomics Pharma brings together alliances you can trust, from preclinical animal and clinical human phase I-IV sites to Consulting services, and a full range of Analytical chemistry and Bioanalytical services. Each member of our service network is FDA-inspected, so you receive scientific expertise with a flexible approach to your testing programs.

Synomics Pharma Alliances and Member Companies

• Pre-Clinical (IND)
  • In-vivo PK (GLP/non-GLP)
  • In-vivo Toxicology (GLP)
  • Animal models of disease
  • Genetic and cellular toxicology
• Clinical (NDA/ANDA)
  • Phase I
  • Phase II
  • Phase III-IV
• Formulations
  • R&D
  • cGMP
• Sterile Fill
• Non-GLP services designed and scaled to fit your discovery budget and needs